1001-8689
2011 Issue 11
Evaluation of cefoperazone/sulbactam susceptibility test of Acinetobacter baumannii in vitro
Lu Ya-min;Zou An-qing;Hou Jia-hui;Fei Jing-xian;Guo Mei-yan;Cao Jian-ming
Lu Ya-min;Zou An-qing;Hou Jia-hui;Fei Jing-xian;Guo Mei-yan;Cao Jian-ming
..............page:872-874
A clinical analysis: Treatment of centralvenous catheter-related fungal septicemia patients with caspofungin
Zheng zhen-cang;Lou xue-ping;Xu Ying-He;Yu Fang-Yu
Zheng zhen-cang;Lou xue-ping;Xu Ying-He;Yu Fang-Yu
..............page:875-877
Breeding high yield mutant strains producing antifungal antibiotic CA-SD07
Jin Jian-ling;Hao Zhao;Wang Wei;Han Wen-zhi;You Zhe-rong;Li Cheng-zhi;Xu Pei-wen
Jin Jian-ling;Hao Zhao;Wang Wei;Han Wen-zhi;You Zhe-rong;Li Cheng-zhi;Xu Pei-wen
..............page:824-828
Relationship between genetic polymorphisms of GSTM1, GSTT1 and the susceptibility to antituberculosis drug-induced liver injury
Zhu Dong-lin;Xi Yun;Wu Xue-qiong
Zhu Dong-lin;Xi Yun;Wu Xue-qiong
..............page:864-868
Clinical analysis of caspofungin in the treatment of invasive fungal infection in old COPD patients
Wu Ji-zhen;Zhao Li-min;Ma Li-jun
Wu Ji-zhen;Zhao Li-min;Ma Li-jun
..............page:869-871
Establishment of microbial limit tests method for bacitracin zinc
Xue Lan;Liang Mei;Ju Jia-xue;Lang Feng-min
Xue Lan;Liang Mei;Ju Jia-xue;Lang Feng-min
..............page:878-880
Study on the separation and purification of 4\'-epi-daunorubicin produced by gene engineering strain SIPI-A0707
Li Wei-ping;Qu Ling-bo;Lu Liang;Shao Lei;Chen Dai-jie;Li Ji-an
Li Wei-ping;Qu Ling-bo;Lu Liang;Shao Lei;Chen Dai-jie;Li Ji-an
..............page:839-843
Studies for decreasing mutant prevention concentration of Staphylococcus aureus by combination of vancomycin and other antibiotics in vitro
Yu Ting;Mei Qing;Zhu Yu-lin;Cheng Jun;Ye Ying;Li Jia-bin
Yu Ting;Mei Qing;Zhu Yu-lin;Cheng Jun;Ye Ying;Li Jia-bin
..............page:859-863
Comparison on the quality and stability between cefpiramide for injection and cefpiramide sodium for injection
Tan Sheng-lian;Zhang Tao;Min Cui-e
Tan Sheng-lian;Zhang Tao;Min Cui-e
..............page:852-854,868
A study of 16S rRNA methylase on Acinetobacter baumannii double-circle resistance to aminoglycoside antibiotic
Zhang Xiao-wen;Shao Hai-feng;Wang Wei-ping;Li Xiao-jun
Zhang Xiao-wen;Shao Hai-feng;Wang Wei-ping;Li Xiao-jun
..............page:855-858
The application of ionic liquids in active pharmaceutical ingredients
Meng Kun-yan;Qi Ming-hui;Chen Yi-liang;Zhao Wen-jie;Ren Guo-bin
Meng Kun-yan;Qi Ming-hui;Chen Yi-liang;Zhao Wen-jie;Ren Guo-bin
..............page:801-805
Impurity profiling of piperacillin sodium and tazobactam sodium for injection by micellar electrokinetic chromatography
Liu Hao;Liu Chang
Liu Hao;Liu Chang
..............page:844-848
Screening, taxonomic identification and metabolite analysis of FADH2-dependent halogenase positive strain 1076 from actinomycetes
Liu Wei-ying;Luo Min-yu;Yin Yu;Chen Dai-jie;Ge Mei;Xu Ji-yang;Qian xiu-ping
Liu Wei-ying;Luo Min-yu;Yin Yu;Chen Dai-jie;Ge Mei;Xu Ji-yang;Qian xiu-ping
..............page:819-823
Drug-resistance in Shigella sonnei: Epidemiology and mechanisms
Bao Chun-mei;Qu Fen
Bao Chun-mei;Qu Fen
..............page:814-818,843
Streptomyces hygroscopicus 17997 produces geldanamycin hydroquinone and its biosynthetic intermediates
Jia Chang-hong;Liu Xin;He Wei-qing;Lin Ling;Zhang Kan;Wang Hong-yuan;Sun Gui-zhi;Wang Yi-guang;Wu Lin-zhuan
Jia Chang-hong;Liu Xin;He Wei-qing;Lin Ling;Zhang Kan;Wang Hong-yuan;Sun Gui-zhi;Wang Yi-guang;Wu Lin-zhuan
..............page:833-838
Headspace GC method determination of residual solvent in cefotetan disodium
Chen Ning;Chen Zhao-yan
Chen Ning;Chen Zhao-yan
..............page:849-851,858
Progress on development situation, mechanism and biosynthesis of rapamycin and its analogs
Li Jin;Zou Xiang
Li Jin;Zou Xiang
..............page:806-813
Effect of precursors on doramectin biosynthesis
Yang Shi-hong;Li Neng-wei;Guo Wei-qun;Han Wei;Chen Xin;Zhang Xiao-lin
Yang Shi-hong;Li Neng-wei;Guo Wei-qun;Han Wei;Chen Xin;Zhang Xiao-lin
..............page:829-832